These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36474156)

  • 1. Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
    Zhang W; Liu Y; Sang A
    BMC Ophthalmol; 2022 Dec; 22(1):472. PubMed ID: 36474156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Injection of Anti-Vascular Endothelial Growth Factors Combined with Corticosteroids for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis.
    Namvar E; Yasemi M; Nowroozzadeh MH; Ahmadieh H
    Semin Ophthalmol; 2024 Jan; 39(1):109-119. PubMed ID: 37621098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion: A meta-analysis.
    Ji K; Zhang Q; Tian M; Xing Y
    Medicine (Baltimore); 2019 May; 98(22):e15798. PubMed ID: 31145307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
    Hu Q; Li H; Xu W; Du Y; Ma C; He J
    Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the One-Year Efficacy of Combined Anti-VEGF and Dexamethasone Implant Treatment for Macular Edema in Retinal Vein Occlusions.
    Ren F; Gong H; Zhang H; Zhang X; Liu X; Li J; Zhang G
    Med Sci Monit; 2023 Jun; 29():e939277. PubMed ID: 37301978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis.
    Qian T; Zhao M; Xu X
    J Clin Pharm Ther; 2017 Oct; 42(5):519-529. PubMed ID: 28639290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination intravitreal anti-vascular endothelial growth factor inhibitors and macular laser photocoagulation relative to intravitreal injection monotherapy in macular oedema secondary to retinal vein occlusion: a meta-analysis of randomized controlled trials.
    Bhambra N; Sayal AP; Popovic MM; Muni RH; Kertes PJ
    Eye (Lond); 2022 Dec; 36(12):2271-2278. PubMed ID: 34819660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
    Gewaily D; Muthuswamy K; Greenberg PB
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007324. PubMed ID: 26352007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the efficacy of dexamethasone implant and anti-VEGF for the treatment of macular edema: A systematic review and meta-analysis.
    Tang HX; Li JJ; Yuan Y; Ling Y; Mei Z; Zou H
    PLoS One; 2024; 19(7):e0305573. PubMed ID: 38985778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Vascular Endothelial Growth Factor Treatment Compared with Steroid Treatment for Retinal Vein Occlusion: A Meta-Analysis.
    Patil NS; Hatamnejad A; Mihalache A; Popovic MM; Kertes PJ; Muni RH
    Ophthalmologica; 2022; 245(6):500-515. PubMed ID: 36288721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.
    Braithwaite T; Nanji AA; Greenberg PB
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007325. PubMed ID: 20927757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficiency of anti-VEGF drugs intravitreal injections treatment with or without retinal laser photocoagulation for macular edema secondary to retinal vein occlusion: A systematic review and meta-analysis.
    Zou W; Du Y; Ji X; Zhang J; Ding H; Chen J; Wang T; Ji F; Huang J
    Front Pharmacol; 2022; 13():948852. PubMed ID: 35935843
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial.
    Song S; Yu X; Zhang P; Gu X; Dai H
    BMC Ophthalmol; 2020 Jun; 20(1):241. PubMed ID: 32560639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
    Lu Y; Su L; Xu X
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):702-8. PubMed ID: 23746130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.